Paper Details

  1. Home
  2. Paper Details

[Controlled comparative trial of acebutolol and bendrofluazide alone or in association for the treatment of hypertension].

Author: WheatleyD

English AbstractA summary of a research paper/publication written in English for a wider audience.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Acebutolol was found to be an effective antihypertensive agent, with fewer side effects than bendrofluazide and an added benefit of anxiety relief.
Paper Details　
Original Abstract of the Article :
The hypotensive effects of acebutolol and bendrofluazide were studied comparatively, used alone or in association, using a permutation method over three consecutive six week periods, in 47 patients aged over 21 whose diastolic pressure prior to treatment was in excess of 100 mm Hg. Whether used alon...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/768909

データ提供：米国国立医学図書館（NLM）

Comparing the Hypotensive Effects of Acebutolol and Bendrofluazide

High blood pressure, like a persistent desert heatwave, can pose a significant threat to health. This study, like a meticulous desert experiment, investigated the hypotensive effects of acebutolol and bendrofluazide, both medications commonly used to treat hypertension. The researchers, like skilled desert scientists, compared the effects of these medications when used alone and in combination. They found that both medications effectively lowered blood pressure, with acebutolol providing additional relief from anxiety, especially when used alone. This study offers valuable insights into the comparative effectiveness of these medications for managing hypertension.

Acebutolol and Bendrofluazide: Exploring Their Potential in Hypertension Management

This research provides valuable insights into the comparative efficacy of acebutolol and bendrofluazide in treating hypertension. The study's findings highlight the potential of both medications to effectively lower blood pressure, with acebutolol offering additional benefits in reducing anxiety.

The Impact on Health and Everyday Life

The study's findings provide valuable information for patients and physicians seeking to manage hypertension. It highlights the potential benefits and considerations associated with acebutolol and bendrofluazide, empowering individuals to make informed decisions about their treatment. The research underscores the importance of individualized treatment plans, taking into account the specific needs and preferences of each patient.

Dr. Camel's Conclusion

This study offers a comprehensive analysis of the hypotensive effects of acebutolol and bendrofluazide, providing valuable insights for managing hypertension. The findings highlight the potential of both medications to effectively lower blood pressure, with acebutolol offering additional benefits in reducing anxiety. The research underscores the importance of a tailored approach to treatment, ensuring that patients receive the most appropriate and effective care.

Date :
  1. Date Completed 1976-05-25
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

768909

DOI: Digital Object Identifier

768909

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.